Mycoplasma pneumoniae induces interleukin-8 production via the epidermal growth factor receptor pathway

Microbiology and Immunology

Volumn 55, Issue 10, 2011, Pages 748-750

  Arae, Ken ^a   Hirata, Masako ^a   Kurata, Satoshi ^b   Kamiya, Shigeru ^b   Taguchi, Haruhiko ^a  

^a KYORIN UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidermal growth factor receptor; Epiregulin; Interleukin 8; Mycoplasma pneumoniae

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EPIREGULIN; G PROTEIN COUPLED RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 8; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BRONCHUS MUCOSA; CYTOKINE PRODUCTION; EPITHELIUM CELL; LUNG ALVEOLUS EPITHELIUM; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION;

CELL LINE; EPIDERMAL GROWTH FACTOR; HUMANS; INTERLEUKIN-8; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

MYCOPLASMA PNEUMONIAE;

EID: 80053295712     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00375.x     Document Type: Article

References (18)

1. Atkinson T.P., Balish M.F., Waites K.B. (2008) Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 32: 956-73.
2. Martin R.J., Chu H.W., Honour J.M., Harbeck R.J. (2001) Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 24: 557-82.
3. Chu H.W., Jeyaseelan S., Rino J.G., Voelker D.R., Wexler R.B., Campbell K., Harbeck R.J., Martin R.J. (2005) TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol 174: 5713-19.
4. Fonseca-Aten M., Rios A.M., Mejias A., Chavez-Bueno S., Katz K., Gomez A.M., McCracken G.H., Hardy R.D. (2005) Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. Am J Respir Cell Mol Biol 32: 201-10.
5. Kurata S., Taguchi H., Sasaki T., Fujioka Y., Kamiya S. (2010) Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae. J Med Microbiol 59: 693-701.
6. Richman-Eisenstat J.B.Y., Jorens P.G., Hebert C.A., Ueki I., Nadel J.A. (1993) Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol Lung Cell Mol Physiol 264: L413-18.
7. Mukaida N. (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284: L566-77.
8. Bohnet S., Kotschau U., Braun J., Dalhoff K. (1997) Role of interleukin-8 in community-acquired pneumonia: relation to microbial load and pulmonary infection. Infection 25: 95-100.
9. Narita M., Tanaka H., Yamada S., Abe S., Ariga T., Sakiyama Y. (2001) Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection. Clin Diagn Lab Immunol 8: 1028-30.
10. Pastore S., Mascia F., Mariani V., Girolomoni G. (2008) The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128: 1365-74.
11. Liu K., Gualano R.C., Hibbs M.L., Anderson G.P., Bozinovski S. (2008) Epidermal growth factor receptor signaling to Erk1/2 and STATs control the intensity of the epithelial inflammatory responses to rhinovirus infection. J Biol Chem 283: 9977-85.
12. Hayakawa M., Taguchi H., Kamiya S., Fujioka Y., Watanabe H., Kawai S., Kobayashi H. (2002) Animal model of Mycoplasma pneumoniae infection using germfree mice. Clin Diagn Lab Immunol 9: 669-76.
13. Sekine H., Taguchi H., Watanabe H., Kawai S., Fujioka Y., Goto H., Kobayashi H., Kamiya S. (2009) Immunological analysis and pathological examination of gnotobiotic mice monoassociated with Mycoplasma pneumoniae. J Med Microbiol 58: 697-705.
14. Shimizu T., Kida Y., Kuwano K. (2005) A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6. J Immunol 175: 4641-6.
15. Shimizu T., Kida Y., Kuwano K. (2007) Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2. Immunology 121: 473-83.
16. Kraft M., Adler K.B., Ingram J.L., Crews A.L., Atkinson T.P., Cairns C.B., Krause D.C., Chu H.W. (2008) Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. Eur Respir J 31: 43-6.
17. Love W., Dobbs N., Tabor L., Simecka J.W. (2010) Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma. PLoS One 5: e10739.
18. Koff J.L., Shao M.X., Ueki I.F., Nadel J.A. (2008) Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol 294: L1068-75.